Literature DB >> 26363509

Lipidomics of Mesenchymal Stromal Cells: Understanding the Adaptation of Phospholipid Profile in Response to Pro-Inflammatory Cytokines.

Ana Margarida Campos1, Elisabete Maciel1, Ana S P Moreira1, Bebiana Sousa1, Tânia Melo1, Pedro Domingues1, Liliana Curado2, Brígida Antunes2, M Rosário M Domingues1, Francisco Santos2.   

Abstract

Mesenchymal stromal cells (MSCs) present anti-inflammatory properties and are being used with great success as treatment for inflammatory and autoimmune diseases. In clinical applications MSCs are subjected to a strong pro-inflammatory environment, essential to their immunosuppressive action. Despite the wide clinical use of these cells, how MSCs exert their effect remains unclear. Several lipids are known to be involved in cell's signaling and modulation of cellular functions. The aim of this paper is to examine the variation in lipid profile of MSCs under pro-inflammatory environment, induced by the presence of tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ), using the most modern lipidomic approach. Major changes in lipid molecular profile of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), lysoPC (LPC), and sphingomyelin (SM) classes were found. No changes were observed in the phosphatidylinositol (PI) profile. The levels of PC species with shorter fatty acids (FAs), mainly C16:0, decreased under pro-inflammatory stimuli. The level of PC(40:6) also decreased, which may be correlated with enhanced levels of LPC(18:0), which is known to be an anti-inflammatory LPC, observed in MSCs subjected to TNF-α and IFN-γ. Simultaneously, the relative amounts of PC(36:1) and PC(38:4) increased. TNF-α and IFN-γ also enhanced the levels of PE(40:6) and decreased the levels of PE(O-38:6). Higher expression of PS(36:1) and SM(34:0) along with a decrease in PS(38:6) levels were observed. These results indicate that lipid metabolism and signaling are modulated during MSCs activation, which suggests that lipids may be involved in MSCs functional and anti-inflammatory activities.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26363509     DOI: 10.1002/jcp.25191

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

Review 1.  Metabolomic biomarkers of low BMD: a systematic review.

Authors:  N Panahi; B Arjmand; A Ostovar; E Kouhestani; R Heshmat; A Soltani; B Larijani
Journal:  Osteoporos Int       Date:  2021-07-26       Impact factor: 4.507

2.  Metabolism and phospholipid assembly of polyunsaturated fatty acids in human bone marrow mesenchymal stromal cells.

Authors:  Feven Tigistu-Sahle; Milla Lampinen; Lotta Kilpinen; Minna Holopainen; Petri Lehenkari; Saara Laitinen; Reijo Käkelä
Journal:  J Lipid Res       Date:  2016-11-16       Impact factor: 5.922

3.  IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate.

Authors:  Lauren Boland; Anthony J Burand; Alex J Brown; Devlin Boyt; Vitor A Lira; James A Ankrum
Journal:  Mol Ther       Date:  2017-12-19       Impact factor: 11.454

4.  Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS.

Authors:  Jun Kou; Chunyang He; Lin Cui; Zhengping Zhang; Wei Wang; Li Tan; Da Liu; Wei Zheng; Wei Gu; Ning Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-19       Impact factor: 6.055

5.  Restored in vivo-like membrane lipidomics positively influence in vitro features of cultured mesenchymal stromal/stem cells derived from human placenta.

Authors:  Alexandros Chatgilialoglu; Martina Rossi; Francesco Alviano; Paola Poggi; Chiara Zannini; Cosetta Marchionni; Francesca Ricci; Pier Luigi Tazzari; Valentina Taglioli; Philip C Calder; Laura Bonsi
Journal:  Stem Cell Res Ther       Date:  2017-02-07       Impact factor: 6.832

6.  Association of Plasma Lipids and Polar Metabolites with Low Bone Mineral Density in Singaporean-Chinese Menopausal Women: A Pilot Study.

Authors:  Diana Cabrera; Marlena Kruger; Frances M Wolber; Nicole C Roy; John J Totman; Christiani Jeyakumar Henry; David Cameron-Smith; Karl Fraser
Journal:  Int J Environ Res Public Health       Date:  2018-05-22       Impact factor: 3.390

Review 7.  Effects of Lipids and Lipoproteins on Mesenchymal Stem Cells Used in Cardiac Tissue Regeneration.

Authors:  Yi-Hsiung Lin; Lin Kang; Wen-Han Feng; Tsung-Lin Cheng; Wei-Chung Tsai; Hsuan-Ti Huang; Hsiang-Chun Lee; Chung-Hwan Chen
Journal:  Int J Mol Sci       Date:  2020-07-05       Impact factor: 5.923

8.  Raman spectroscopy uncovers biochemical tissue-related features of extracellular vesicles from mesenchymal stromal cells.

Authors:  Alice Gualerzi; Stefania Niada; Chiara Giannasi; Silvia Picciolini; Carlo Morasso; Renzo Vanna; Valeria Rossella; Massimo Masserini; Marzia Bedoni; Fabio Ciceri; Maria Ester Bernardo; Anna Teresa Brini; Furio Gramatica
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

9.  Development of suspension cell culture model to mimic circulating tumor cells.

Authors:  Ji Young Park; Ae Lee Jeong; Hyun Jeong Joo; Sora Han; So-Hyun Kim; Hye-Youn Kim; Jong-Seok Lim; Myeong-Sok Lee; Hyung-Kyoon Choi; Young Yang
Journal:  Oncotarget       Date:  2017-12-07

10.  Ultra-High Mass Resolving Power, Mass Accuracy, and Dynamic Range MALDI Mass Spectrometry Imaging by 21-T FT-ICR MS.

Authors:  Andrew P Bowman; Greg T Blakney; Christopher L Hendrickson; Shane R Ellis; Ron M A Heeren; Donald F Smith
Journal:  Anal Chem       Date:  2020-02-03       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.